- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
India blessed to have Serum Institute, says World Bank President David Malpass
Washington: World Bank President David Malpass has said that with the Serum Institute, India is blessed to have a major manufacturer of global vaccines and he is encouraged by the country's ramping up of its domestic vaccination programme.
Malpass made the comments on Monday during a media roundtable ahead of the spring meeting of the International Monetary Fund and World Bank.
I've had substantial contact with the Serum Institute. India is blessed with having a major manufacturer of global vaccines in India, he said.
Responding to a question, Malpass said that he has encouraged more transparency in terms of what the national requirements are for local production, and that extends to countries around the world.
It hasn't been clear, whether in the United States or in Europe, or in South Africa, or in India, what the requirements are of their local production to meet local demands. I've been encouraged by India's ramping up of its domestic vaccination programme, and we're working with them on that. This is a high priority for the world, Malpass said.
Because capacity constraints are immense, it takes a lot of people to do the scale of vaccination campaign that we are conducting, he said.
The Health Ministry on Saturday said that the India has administered a total of 7,06,18,026 COVID-19 vaccine doses till Friday.
As such, Malpass said it is important and vital to have early delivery of vaccines to developing countries because it's going to take a long time to actually do the vaccinations.
So, I think one of the highest priorities for the world is to begin allowing the supply of vaccines to go to developing countries themselves, including the poorest countries, so that the vaccination process can get under way, Malpass said.
By the middle of this year, he said, the World Bank will have 50 countries with the financing contracts in place that allow the funding to be used to buy vaccines as those become available from around the world. The bank is working actively on that, he said.
India, he said, is the World Bank's biggest programme, and as such he mentioned climate change issues.
As we work with India and the transitions that are done in order to have cleaner, lower-carbon fuels for electricity, all forms of energy is going to be one of the world's highest challenges, and I know India is working directly on that itself. It's an important country within the world's mix in terms of both greenhouse gas emissions and in terms of adaptation, Malpass said.
According to the Johns Hopkins University data, there are 131,666,045 COVID-19 cases worldwide with 2,858,491 deaths.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751